Feb. 15 at 10:24 PM
$INSP - Inspire Medical Systems Inc - 10K - Updated Risk Factors
INSP’s 2026 10-K sharpens risks around stock volatility and securities suits, tougher global competition including GLP-1 drugs, expanded reimbursement and regulatory hurdles (QMSR, MDR, AI, healthcare reform, OBBBA), rising litigation and IP battles with Nyxoah, supply-chain and demand-forecasting strain, ESG and cyber scrutiny, and new tax and dividend policies impacting shareholder returns. #MedicalDevices #HealthcareReform #RegulatoryRisks #LitigationRisk #SupplyChain
🟢 Added 🟠 Removed
https://d-risk.ai/INSP/10-K/2026-02-13